Mapping large numbers of results may take a few moments.
Search Results
Showing 51 - 100 of 210 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company CardioPharma Inc. | Activity: Research and Development | Company Description CardioPharma develops combinatorial products to treat cardiovascular disease. | Location Wilmington |
| |
Company Catalent Pharma Solutions LLC (Greenville) | Activity: Production and Manufacturing | Company Description Catalent Pharma Solutions manufactures oral solid dosage forms, including integrated formulation development, analytical services, commercial manufacturing, and packaging. | Location Greenville |
| |
Company Catalent Pharma Solutions LLC (Morrisville) | Activity: Contract Research and Testing | Company Description Catalent provides drug development and manufacturing services for the pharma, biotech and consumer sectors. Core offerings include biologics, parenterals, oral solids, softgel, inhalation, clinical supply services and analytical services. | Location Morrisville |
| |
Company Chiesi USA Inc. | Activity: Research and Development | Company Description Chiesi USA, the U.S. affiliate of Chiesi Farmaceutici S.p.A, develops and commercializes products in the therapeutic areas of rare disease, respiratory, cardiovascular, neonatology and cystic fibrosis. | Location Cary |
| |
Company Chimerix Inc. | Activity: Research and Development | Company Description Chimerix discovers, develops and commercializes broad spectrum antivirals for the prevention and treatment of life-threatening viral infections. | Location Durham |
| |
Company Cloud Pharmaceuticals Inc. | Activity: Contract Research and Testing | Company Description Cloud Pharmaceuticals designs and develops novel drug molecules using computational design for a wide range of therapeutic areas including cancer, inflammation, CNS disorders and rare diseases. | Location Research Triangle Park |
| |
Company CMP Pharma Inc. | Activity: Production and Manufacturing | Company Description CMP develops, manufactures and commercializes niche oral liquid medications that address the needs of patients with difficulty swallowing solid dosage forms. | Location Farmville |
| |
Company CogniKey Pharma LLC | Activity: Contract Research and Testing | Company Description CogniKey Pharma develops drugs to treat cognitive impairment in CNS disorders. CogniKey has a special interest in the treatment of Mild Cognitive Impairment (MCI). | Location Winston-Salem |
| |
Company Cognosci Inc. | Activity: Research and Development | Company Description Cognosci develops neurorestorative therapies for Alzheimer's disease, multiple sclerosis, traumatic brain injury, nerve crush and other disease and trauma indications. | Location Durham |
| |
Company Collaborations Pharmaceuticals Inc. | Activity: Contract Research and Testing | Company Description Collaborations Pharmaceuticals develops drugs for rare and neglected diseases using machine learning software, providing preclinical and clinical expertise to rare disease foundations, academic scientists and companies developing clinical candidates. Collaborations also provides machine learning expertise and software to consumer product and agrochemical companies. | Location Raleigh |
| |
Company Cosette Pharmaceuticals | Activity: Production and Manufacturing | Company Description Cosette Pharmaceuticals manufactures OTC and prescription hydrocortisone, antifungal and permethrin products such as creams, ointments, liquids and suppositories. | Location Lincolnton |
| |
Company Countervail Corp. | Activity: Research and Development | Company Description Countervail is developing proprietary drug and diagnostic technologies to detect exposure to and prevent adverse effects from organophosphate pesticides. | Location Mint Hill |
| |
Company Dechra Pharmaceuticals | Activity: Research and Development | Company Description Dechra Pharmaceuticals develops veterinary pharmaceuticals with a focus on major companion animal categories. | Location Greensboro |
| |
Company DelAQUA Pharmaceuticals Inc. | Activity: Research and Development | Company Description DelAQUA Pharmaceuticals is developing technology to enhance the solubility and stability of drugs and drug candidates and to improve their efficacy and safety. | Location Chapel Hill |
| |
Company Dermavant Sciences | Activity: Research and Development | Company Description Dermavant, a part of the Roivant family of companies, develops therapies for the treatment of skin diseases. | Location Morrisville |
| |
Company Dignify Therapeutics LLC | Activity: Research and Development | Company Description Dignify Therapeutics develops novel bowel and bladder therapies for people with neurological disorders and the elderly that suffer from incontinence. | Location Research Triangle Park |
| |
Company Drive Therapeutics LLC | Activity: Research and Development | Company Description Drive Therapeutics is developing therapeutics for wet age-related macular degeneration (wAMD) and diabetic retinopathy/diabetic macular edema (DR/DME). | Location Research Triangle Park |
| |
Company Eclipse Life Sciences Inc. | Activity: Research and Development | Company Description Eclipse Life Sciences is developing therapeutic compounds to treat front-of-the-eye diseases, such as uveitis and dry eye, as well as back-of-the-eye diseases, such as wet or dry macular degeneration or diabetic retinopathy. | Location Research Triangle Park |
| |
Company Eisai Inc. | Activity: Sales and Operations | Company Description Eisai discovers, develops and markets pharmaceuticals in neurology and oncology-critical care. This site supports global partnerships, quality assurance and supply chain for the company. | Location Raleigh |
| |
Company Emergo Therapeutics Inc. | Activity: Research and Development | Company Description Emergo Therapeutics develops drugs to reduce the production of inflammatory cytokines from mast cells and improve the functioning of the immune system in various potential indications, starting with infectious diseases. | Location Durham |
| |
Company Endacea Inc. | Activity: Research and Development | Company Description Endacea develops A1 adenosine receptor antagonists as drug candidates for cancer, COVID-19 acute lung injury, sepsis and acute renal failure. | Location Research Triangle Park |
| |
Company ENVIGEN Pharmaceuticals Inc. | Activity: Research and Development | Company Description ENVIGEN develops classes of small drug-like molecules to treat life-threatening diseases including cancer, HIV/AIDS and neurological disorders. | Location Durham |
| |
Company Eppin Pharma Inc. | Activity: Research and Development | Company Description Eppin Pharma is developing a non-hormonal male oral contraceptive. | Location Durham |
| |
Company ER Therapeutics LLC | Activity: Research and Development | Company Description ER Therapeutics is developing and commercializing therapeutics for cancer. | Location Chapel Hill |
| |
Company Eurofins BioPharma Product Testing ENCO Inc. | Activity: Contract Research and Testing | Company Description Eurofins BioPharma Product Testing ENCO provides stability studies and analytical services to industrial, consulting and government customers. | Location Cary |
| |
Company Evecxia Inc. | Activity: Research and Development | Company Description Evecxia is developing drugs which amplify serotonin synthesis to treat neuropsychiatric conditions for which current therapies are inadequate. | Location Research Triangle Park |
| |
Company Exela Pharma Sciences LLC | Activity: Production and Manufacturing | Company Description Exela Pharma Sciences develops, manufactures and markets sterile injectable pharmaceuticals and provides contract manufacturing services. The Lenoir site is a cGMP-compliant sterile manufacturing facility. | Location Lenoir |
| |
Company EydisBio Inc. | Activity: Research and Development | Company Description Eydis Bio is developing a platform of small molecule therapeutics targeting a variety of diseases driven by aberrant inflammatory/autoimmune processes. | Location Durham |
| |
Company Eyedesis Biosciences LLC | Activity: Research and Development | Company Description Eyedesis Biosciences is developing a small-molecule macrophage inhibitor for the treatment of neovascular age related macular degeneration. | Location Chapel Hill |
| |
Company Fennec Pharmaceuticals Inc. | Activity: Research and Development | Company Description Fennec Pharmaceuticals develops a sodium thiosulfate formula for the prevention of ototoxicity from cisplatin in pediatric patients. | Location Research Triangle Park |
| |
Company Fernel Therapeutics Inc. | Activity: Research and Development | Company Description Fernel Therapeutics develops medical devices and pharmaceuticals for the treatment of benign or non-infectious diseases of the pelvic region. | Location Apex |
| |
Company Fervent Pharmaceuticals LLC | Activity: Research and Development | Company Description Fervent Pharmaceuticals develops a nonhormonal product, FP-101, to treat vasomotor symptoms associated with menopause. | Location Greenville |
| |
Company FHI 360 | Activity: Contract Research and Testing | Company Description FHI 360 is a nonprofit human development organization working to improve the health and well-being of people in the U.S. and around the world. The laboratory in Durham offers medical device and pharmaceutical testing services. | Location Durham |
| |
Company FLAG Therapeutics Inc. | Activity: Research and Development | Company Description FLAG Therapeutics develops cancer therapeutics using new classes of small molecules which have selective dual activity: antiangiogenesis and chemotherapeutic. | Location Raleigh |
| |
Company FUJIFILM Diosynth Biotechnologies USA Inc. (Morrisville) | Activity: Production and Manufacturing | Company Description FUJIFILM Diosynth Biotechnologies is a contract development and manufacturing organization for biologics, vaccines, cell and gene therapies, and oncolytic viruses. Services include cell line development, process and analytical development, clinical and commercial manufacturing and bioprocess research and development. | Location Morrisville |
| |
Company G1 Therapeutics Inc. | Activity: Research and Development | Company Description G1 Therapeutics is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for those affected by cancer. | Location Research Triangle Park |
| |
Company Genebiology Inc. | Activity: Research and Development | Company Description GeneBiology identifies, patents and develops new parenteral formulations of approved drugs for unmet medical needs using the 505b2 regulatory pathway. | Location Research Triangle Park |
| |
Company Generys Biopharmaceuticals Corp. | Activity: Research and Development | Company Description Generys BioPharmaceuticals develops drugs, formulations and generics for unmet medical needs. Generys also offers therapeutic pipeline portfolio consulting and management services on a contract basis. | Location Chapel Hill |
| |
Company Glenmark Pharmaceuticals Inc., USA | Activity: Production and Manufacturing | Company Description Glenmark Pharmaceuticals discovers small-molecule drugs and biologics in the areas of oncology, respiratory disease and dermatology, and manufactures and distributes APIs and generics. The Monroe site manufactures oral solids, injectables and topicals. | Location Monroe |
| |
Company Glycomine Inc. | Activity: Research and Development | Company Description Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding. | Location Chapel Hill |
| |
Company GSK (Durham) | Activity: Research and Development | Company Description GSK develops and manufactures vaccines and medicines, with a focus on science related to the immune system, human genetics and advanced technologies. | Location Durham |
| |
Company GSK (Zebulon) | Activity: Production and Manufacturing | Company Description GlaxoSmithKline manufactures solid-dose products, including tablets and capsules, at its Zebulon facility. The plant also does granulation, drying and packaging, and contract manufacturing of antibiotics for other companies. | Location Zebulon |
| |
Company Hudson Therapeutics Inc. | Activity: Research and Development | Company Description Hudson Therapeutics, a subsidiary of Shaperon Inc., conducts global clinical trials and business development for anti-inflammatory and immunology drugs. | Location Research Triangle Park |
| |
Company IMMvention Therapeutix Inc. | Activity: Research and Development | Company Description IMMvention develops small molecule therapies that inhibit multiple inflammasome receptors to treat both rare and prevalent inflammatory diseases. | Location Research Triangle Park |
| |
Company Imugene Limited (Durham) | Activity: Research and Development | Company Description Imugene is a clinical stage immuno-oncology company developing treatments that seek to activate the immune system of cancer patients to identify and eradicate tumors. | Location Durham |
| |
Company Incyclix Bio LLC | Activity: Research and Development | Company Description Incyclix Bio is developing novel cancer treatments through the selective inhibition of specific CDK (cyclin-dependent kinase) family members to address unmet medical needs of oncology patients. | Location Research Triangle Park |
| |
Company Invitrox Inc. | Activity: Contract Research and Testing | Company Description Invitrox provides GLP-compliant bioanalytical services for nonclinical and clinical drug development studies, with expertise in method development and validation, small and large molecules, sample analysis, metabolites, biomarkers and drug monitoring. | Location Research Triangle Park |
| |
Company Irex Pharma LLC | Activity: Research and Development | Company Description Irex Pharma is an early-stage drug discovery company focused on identifying and commercializing novel therapeutics to control excess mucus in pulmonary patients. | Location Chapel Hill |
| |
Company Ironshore Pharmaceuticals Inc. | Activity: Sales and Operations | Company Description Ironshore Pharmaceuticals develops, commercializes and distributes novel pharmaceuticals, including a novel oral treatment for ADHD with delayed-release properties. | Location Morrisville |
| |
Company Jericho Sciences LLC | Activity: Research and Development | Company Description Jericho Sciences is developing antiviral therapeutics and corresponding personalized diagnostic assays which specifically address the limitations of current combination antiretroviral therapy (cART) in the clinical management of HIV-1 infection to reduce underlying sources of persistent virus. | Location Durham |